The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Editas Medicine Inc (EDIT) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.25, or 2.83%, to $9.09. The Editas Medicine Inc has recorded 44,856 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Editas Medicine Announces Third Quarter 2023 Results and Business Updates.
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $8.84 and fluctuated between $9.15 as its day high and $8.50 as its day low. The current market capitalization of Editas Medicine Inc is $721.96M. A total of 1.73 million shares were traded on the day, compared to an average of 1.53M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, EDIT has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 103 shares. Over the last 12 months, there were 6 BUYs and 18 SELLs from insiders. Insiders purchased 239,267 shares during that period but sold 26,668.
In the most recent transaction, Eaton Bruce sold 139 shares of EDIT for 8.40 per share on Nov 07. After the transaction, the EVP, CBO AND CTO now owns 75,589 company shares. In a previous transaction on Sep 06, Eaton Bruce sold 103 shares at 8.82 per share. EDIT shares that EVP, CBO AND CTO owns now total 75,728.
Among the insiders who sold shares, Eaton Bruce disposed of 702 shares on Aug 11 at a per-share price of $8.59. This resulted in the EVP, CBO AND CTO holding 75,831 shares of EDIT after the transaction. In another insider transaction, Eaton Bruce sold 141 shares at $8.39 per share on Aug 08. Company shares held by the EVP, CBO AND CTO now total 76,533.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for EDIT in the last 3 months, the mean price target is $13.93 with high estimates of $27.00 and low estimates of $7.00. In terms of 52-week highs and lows, EDIT has a high of $13.94 and a low of $6.08.
As of this writing, EDIT has an earnings estimate of -$0.62 per share for the current quarter. EPS was calculated based on a consensus of 16 estimates, with a high estimate of -$0.36 per share and a lower estimate of -$0.83. The company reported an EPS of -$0.56 in the last quarter, which was 26.30% higher than expectations of -$0.76.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. EDIT’s latest balance sheet shows that the firm has $619.91M in Cash & Short Term Investments as of fiscal 2021. There were $26.38M in debt and $46.88M in liabilities at the time. Its Book Value Per Share was $4.41, while its Total Shareholder’s Equity was $553.64M.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EDIT is Buy with a score of 3.88.